Cita APA (7a ed.)
Ryan, S., Visgauss, J., Kerr, D., Helmkamp, J., Said, N., Vinson, E., . . . Brigman, B. (2018, March 19). The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing. Sarcoma, 1-8.
Cita Chicago Style (17a ed.)
Ryan, Sean, et al. "The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing." Sarcoma 19 Mar. 2018: 1-8.
Cita MLA (9a ed.)
Ryan, Sean, et al. "The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing." Sarcoma, 19 Mar. 2018, pp. 1-8.
Precaución: Estas citas no son 100% exactas.